Atlas Venture Advisors, Inc. - Q1 2021 holdings

$542 Million is the total value of Atlas Venture Advisors, Inc.'s 8 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .

 Value Shares↓ Weighting
DKNG  DRAFTKINGS INC$446,728,000
+31.7%
7,284,0080.0%82.49%
+8.5%
TBIO SellTRANSLATE BIO INC$30,871,000
-36.9%
1,872,115
-29.5%
5.70%
-48.1%
ROKU  ROKU INC$18,799,000
-1.9%
57,7070.0%3.47%
-19.2%
BCYC  BICYCLE THERAPEUTICS PLCsponsored ads$18,301,000
+66.4%
612,6960.0%3.38%
+37.0%
SNAP  SNAP INCcl a$12,841,000
+4.4%
245,5590.0%2.37%
-14.0%
FSTX  F-STAR THERAPEUTICS INC$6,227,000
+9.7%
574,9960.0%1.15%
-9.7%
LRMR  LARIMAR THERAPEUTICS INC$4,269,000
-31.8%
292,1840.0%0.79%
-43.8%
VRDN  VIRIDIAN THERAPEUTICS INC$3,501,000
+1.6%
209,5050.0%0.65%
-16.4%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SNAP INC20Q3 20236.1%
ROKU INC16Q3 202311.7%
LARIMAR THERAPEUTICS INC14Q3 20231.4%
TRANSLATE BIO INC11Q2 202152.9%
INTEGRAL AD SCIENCE HLDNG CO10Q3 202371.2%
BICYCLE THERAPEUTICS PLC10Q3 202125.2%
VIRIDIAN THERAPEUTICS INC10Q1 20232.1%
F-STAR THERAPEUTICS INC9Q4 20221.3%
DRAFTKINGS INC8Q1 202282.5%
MIRAGEN THERAPEUTICS INC8Q3 20205.0%

View Atlas Venture Advisors, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04

View Atlas Venture Advisors, Inc.'s complete filings history.

Compare quarters

Export Atlas Venture Advisors, Inc.'s holdings